How does A432980's PB Ratio compare to its peers?

Insufficient data to calculate A432980's Price-To-Book Ratio vs. peers for valuation analysis.

How does A432980's PB Ratio compare vs other companies in the KR Pharmaceuticals Industry?

Insufficient data to calculate A432980's Price-To-Book Ratio vs. industry for valuation analysis.

What is A432980's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate A432980's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of A432980 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate A432980's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

MFC KOSE:A432980 Stock Report

Last Price

₩5.33k

Market Cap

₩45.8b

7D

-13.3%

1Y

n/a

Updated

03 Jan, 2025

Data

Company Financials

MFC Co., Ltd.

KOSE:A432980 Stock Report

Market Cap: ₩45.8b

A432980 Stock Overview

Mfc Co., Ltd. manufactures basic pharmaceutical substances and biological products. More details

A432980 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Shares are highly illiquid

Does not have a meaningful market cap (₩46B)

My Notes

Capture your thoughts, links and company narrative

MFC Co., Ltd. Competitors

MYUNGMOON PharmLtd

KOSE:A017180

₩61.8b

Eagle Veterinary TechnologyLtd

KOSDAQ:A044960

₩60.8b

Cheilbio

KOSDAQ:A052670

₩56.2b

Jin Yang Pharmaceutical

KOSDAQ:A007370

₩69.6b

Price History & Performance

Summary of share price highs, lows and changes for MFC
Historical stock prices
Current Share Price	₩5,330.00
52 Week High	₩8,440.00
52 Week Low	₩5,300.00
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-25.77%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	A432980	KR Pharmaceuticals	KR Market
7D	-13.3%	4.8%	2.2%
1Y	n/a	1.8%	-8.3%

Return vs Industry: Insufficient data to determine how A432980 performed against the KR Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how A432980 performed against the KR Market.

Price Volatility

Is A432980's price volatile compared to industry and market?
A432980 volatility
A432980 Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	5.5%
Market Average Movement	6.6%
10% most volatile stocks in KR Market	12.8%
10% least volatile stocks in KR Market	3.4%

Stable Share Price: A432980's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: Insufficient data to determine A432980's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2008	n/a	n/a	n/a

Mfc Co., Ltd. manufactures basic pharmaceutical substances and biological products. The company was incorporated in 2008 and is based in Hwaseong-si, South Korea.

MFC Co., Ltd. Fundamentals Summary

How do MFC's earnings and revenue compare to its market cap?
A432980 fundamental statistics
Market cap	₩45.79b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A432980 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A432980 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A432980 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/03 17:08
End of Day Share Price	2025/01/03 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MFC Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution